Evidence map›Paper›PMID 34442412›Full record

ArticleJournal of personalized medicine2021

Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma.

Robert J Smyth, Valentina Thomas, Joanna Fay, Ronan Ryan, Siobhan Nicholson, Ross K Morgan, Liam Grogan, Oscar Breathnach, Patrick G Morris, Sinead Toomey and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Case report:Frontiers in oncology · 2024
    Article
  3. [Expression of MEF2D in Lung Adenocarcinoma and Its Correlation with Prognosis].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Robert J SmythDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.ORCID 0000-0001-7613-9306
Valentina ThomasGenomic Oncology Research Group, Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.ORCID 0000-0001-8866-8627
Joanna FayDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
Ronan RyanDepartment of Histopathology, St James's Hospital, D08 NHY1 Dublin, Ireland.
Siobhan NicholsonDepartment of Histopathology, St James's Hospital, D08 NHY1 Dublin, Ireland.
Ross K MorganDepartment of Respiratory Medicine, Beaumont Hospital, Dublin and Royal College of Surgeons of Ireland, D02 YN77 Dublin, Ireland.
Liam GroganDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
Oscar BreathnachDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
Patrick G MorrisDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
Sinead ToomeyDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
Bryan T HennessyDepartment of Molecular Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
Simon J FurneyGenomic Oncology Research Group, Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.ORCID 0000-0002-8920-6800
Royal College of Surgeons in Ireland · IESt. James's Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary enteric adenocarcinoma (PEAC) is a rare variant of lung adenocarcinoma first described in the early 1990s in a lung tumour with overlapping lung and small intestine features. It is a rare tumour with fewer than 300 cases described in the published literature and was only formally classified in 2011. Given these characteristics the diagnosis is challenging, but even more so in a patient with prior gastrointestinal malignancy. A 68-year-old Caucasian female presented with a cough and was found to have a right upper lobe mass. Her history was significant for a pT3N1 colon adenocarcinoma. The resected lung tumour showed invasive lung adenocarcinoma but also features of colorectal origin. Immuno-stains were strongly and diffusely positive for lung and enteric markers. Multi-region, whole-exome sequencing of the mass and archival tissue from the prior colorectal cancer showed distinct genomic signatures with higher mutational burden in the PEAC and very minimal overlap in mutations between the two tumours. This case highlights the challenge of diagnosing rare lung tumours, but more specifically PEAC in a patient with prior gastro-intestinal cancer. Our use of multi-region, next-generation sequencing revealed distinct genomic signatures between the two tumours further supporting our diagnosis, and evidence of PEAC intra-tumour heterogeneity.

Indexed as

colorectal adenocarcinomaintratumour heterogeneitymutational burdenpulmonary enteric adenocarcinomawhole-exome sequencing

Identifiers

PMID34442412
PMCPMC8398793
OpenAlexW3190080167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.